Does the media favor MBOT or SI?

In the previous week, Shoulder Innovations had 1 more articles in the media than Microbot Medical. MarketBeat recorded 4 mentions for Shoulder Innovations and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.45 beat Shoulder Innovations' score of 0.34 indicating that Microbot Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Shoulder Innovations 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor MBOT or OBIO?

In the previous week, Orchestra BioMed had 3 more articles in the media than Microbot Medical. MarketBeat recorded 6 mentions for Orchestra BioMed and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.45 beat Orchestra BioMed's score of 0.35 indicating that Microbot Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Orchestra BioMed 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to MBOT or SENS?

In the previous week, Microbot Medical had 2 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 3 mentions for Microbot Medical and 1 mentions for Senseonics Holdings, Inc. Common Stock. Microbot Medical's average media sentiment score of 0.45 beat Senseonics Holdings, Inc. Common Stock's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Senseonics Holdings, Inc. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to MBOT or OFIX?

In the previous week, Microbot Medical had 1 more articles in the media than Orthofix Medical. MarketBeat recorded 3 mentions for Microbot Medical and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 0.51 beat Microbot Medical's score of 0.45 indicating that Orthofix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Orthofix Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is MBOT or MOBI more profitable?

Mobia Medical's return on equity of 0.00% beat Microbot Medical's return on equity. Company Net Margins Return on Equity Return on Assets Microbot Medical N/A -21.87% -20.76% Mobia Medical N/A N/A N/A

Does the media prefer MBOT or MOBI?

In the previous week, Mobia Medical had 1 more articles in the media than Microbot Medical. MarketBeat recorded 4 mentions for Mobia Medical and 3 mentions for Microbot Medical. Mobia Medical's average media sentiment score of 1.19 beat Microbot Medical's score of 0.45 indicating that Mobia Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mobia Medical 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Microbot Medical (MBOT) Competitors

$1.36 -0.06 (-4.23%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$1.38 +0.01 (+1.10%)

As of 09/18/2026 07:58 PM Eastern

Compare

MBOT vs. SI, OBIO, SENS, OFIX, and MOBI

Should you buy Microbot Medical stock or one of its competitors? Microbot Medical's main competitors and comparable companies include Shoulder Innovations (SI), Orchestra BioMed (OBIO), Senseonics Holdings, Inc. Common Stock (SENS), Orthofix Medical (OFIX), and Mobia Medical (MOBI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Microbot Medical compare to Shoulder Innovations?

Microbot Medical (NASDAQ:MBOT) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Microbot Medical currently has a consensus target price of $6.38, suggesting a potential upside of 368.75%. Shoulder Innovations has a consensus target price of $25.50, suggesting a potential upside of 40.33%. Given Microbot Medical's higher probable upside, research analysts plainly believe Microbot Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, Shoulder Innovations had 1 more articles in the media than Microbot Medical. MarketBeat recorded 4 mentions for Shoulder Innovations and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.45 beat Shoulder Innovations' score of 0.34 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Shoulder Innovations	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Microbot Medical has a net margin of 0.00% compared to Shoulder Innovations' net margin of -58.33%. Microbot Medical's return on equity of -21.87% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.87%	-20.76%
Shoulder Innovations	-58.33%	-23.61%	-19.53%

16.3% of Microbot Medical shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Comparatively, 29.0% of Shoulder Innovations shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Microbot Medical has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market. Comparatively, Shoulder Innovations has a beta of -1.77, suggesting that its share price is 277% less volatile than the broader market.

Microbot Medical has higher earnings, but lower revenue than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.24	N/A
Shoulder Innovations	$47.32M	8.00	-$40.36M	-$1.92	N/A

Summary

Microbot Medical beats Shoulder Innovations on 9 of the 15 factors compared between the two stocks.

How does Microbot Medical compare to Orchestra BioMed?

Microbot Medical (NASDAQ:MBOT) and Orchestra BioMed (NASDAQ:OBIO) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

Microbot Medical has higher earnings, but lower revenue than Orchestra BioMed. Orchestra BioMed is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.24	N/A
Orchestra BioMed	$33.48M	10.91	-$52.70M	-$0.85	N/A

Microbot Medical presently has a consensus target price of $6.38, indicating a potential upside of 368.75%. Orchestra BioMed has a consensus target price of $13.17, indicating a potential upside of 116.56%. Given Microbot Medical's higher probable upside, equities analysts clearly believe Microbot Medical is more favorable than Orchestra BioMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Orchestra BioMed	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75

Microbot Medical has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Orchestra BioMed has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

In the previous week, Orchestra BioMed had 3 more articles in the media than Microbot Medical. MarketBeat recorded 6 mentions for Orchestra BioMed and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.45 beat Orchestra BioMed's score of 0.35 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Orchestra BioMed	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Microbot Medical has a net margin of 0.00% compared to Orchestra BioMed's net margin of -184.60%. Microbot Medical's return on equity of -21.87% beat Orchestra BioMed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.87%	-20.76%
Orchestra BioMed	-184.60%	-149.61%	-54.15%

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 53.2% of Orchestra BioMed shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 7.5% of Orchestra BioMed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Microbot Medical beats Orchestra BioMed on 9 of the 15 factors compared between the two stocks.

How does Microbot Medical compare to Senseonics Holdings, Inc. Common Stock?

Microbot Medical (NASDAQ:MBOT) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability.

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Microbot Medical had 2 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 3 mentions for Microbot Medical and 1 mentions for Senseonics Holdings, Inc. Common Stock. Microbot Medical's average media sentiment score of 0.45 beat Senseonics Holdings, Inc. Common Stock's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Senseonics Holdings, Inc. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Microbot Medical has a net margin of 0.00% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Microbot Medical's return on equity of -21.87% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.87%	-20.76%
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%

Microbot Medical has higher earnings, but lower revenue than Senseonics Holdings, Inc. Common Stock. Microbot Medical is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.24	N/A
Senseonics Holdings, Inc. Common Stock	$35.26M	11.36	-$69.11M	-$2.23	N/A

Microbot Medical has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market.

Microbot Medical currently has a consensus target price of $6.38, suggesting a potential upside of 368.75%. Senseonics Holdings, Inc. Common Stock has a consensus target price of $17.20, suggesting a potential upside of 79.54%. Given Microbot Medical's higher possible upside, research analysts plainly believe Microbot Medical is more favorable than Senseonics Holdings, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Microbot Medical beats Senseonics Holdings, Inc. Common Stock on 10 of the 15 factors compared between the two stocks.

How does Microbot Medical compare to Orthofix Medical?

Microbot Medical (NASDAQ:MBOT) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Microbot Medical had 1 more articles in the media than Orthofix Medical. MarketBeat recorded 3 mentions for Microbot Medical and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 0.51 beat Microbot Medical's score of 0.45 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Orthofix Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Microbot Medical has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

Microbot Medical currently has a consensus target price of $6.38, suggesting a potential upside of 368.75%. Orthofix Medical has a consensus target price of $14.75, suggesting a potential upside of 69.35%. Given Microbot Medical's higher possible upside, analysts clearly believe Microbot Medical is more favorable than Orthofix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Microbot Medical has a net margin of 0.00% compared to Orthofix Medical's net margin of -7.41%. Orthofix Medical's return on equity of -14.05% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.87%	-20.76%
Orthofix Medical	-7.41%	-14.05%	-7.17%

Microbot Medical has higher earnings, but lower revenue than Orthofix Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.24	N/A
Orthofix Medical	$822.31M	0.43	-$92.19M	-$1.54	N/A

Summary

Microbot Medical beats Orthofix Medical on 7 of the 13 factors compared between the two stocks.

How does Microbot Medical compare to Mobia Medical?

Microbot Medical (NASDAQ:MBOT) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

16.3% of Microbot Medical shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Microbot Medical currently has a consensus target price of $6.38, suggesting a potential upside of 368.75%. Mobia Medical has a consensus target price of $20.75, suggesting a potential upside of 96.87%. Given Microbot Medical's higher possible upside, analysts clearly believe Microbot Medical is more favorable than Mobia Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Microbot Medical has higher earnings, but lower revenue than Mobia Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.24	N/A
Mobia Medical	$32.04M	10.95	-$46.50M	-$20.18	N/A

In the previous week, Mobia Medical had 1 more articles in the media than Microbot Medical. MarketBeat recorded 4 mentions for Mobia Medical and 3 mentions for Microbot Medical. Mobia Medical's average media sentiment score of 1.19 beat Microbot Medical's score of 0.45 indicating that Mobia Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mobia Medical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mobia Medical's return on equity of 0.00% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.87%	-20.76%
Mobia Medical	N/A	N/A	N/A

Summary

Mobia Medical beats Microbot Medical on 8 of the 13 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MBOT vs. The Competition

Export

Metric	Microbot Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$91.34M	$5.55B	$7.24B	$13.19B
Dividend Yield	N/A	1.80%	2.57%	12.81%
P/E Ratio	-5.67	25.34	274.93	25.38
Price / Sales	N/A	72.49	646.01	89.45
Price / Cash	N/A	32.64	76.25	51.42
Price / Book	1.18	5.69	10.46	6.33
Net Income	-$13.14M	$151.55M	$3.49B	$358.33M
7 Day Performance	-6.21%	0.66%	0.59%	1.12%
1 Month Performance	-8.72%	-3.33%	-1.74%	-2.39%
1 Year Performance	-57.37%	6.79%	18.13%	5.35%

Microbot Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MBOT Microbot Medical	2.1099 of 5 stars	$1.36 -4.2%	$6.38 +368.8%	-57.4%	$91.34M	N/A	N/A	22	News Coverage Analyst Upgrade
SI Shoulder Innovations	3.0324 of 5 stars	$18.29 -1.3%	$25.50 +39.4%	+23.1%	$385.77M	$47.32M	N/A	75
OBIO Orchestra BioMed	3.6231 of 5 stars	$5.90 -3.6%	$13.00 +120.3%	+149.2%	$367.84M	$31.98M	N/A	4	Analyst Forecast
SENS Senseonics Holdings, Inc. Common Stock	2.6838 of 5 stars	$8.84 +1.5%	$17.20 +94.6%	N/A	$364.10M	$48.55M	N/A	130	News Coverage Analyst Upgrade
OFIX Orthofix Medical	3.0209 of 5 stars	$9.11 +2.0%	$14.75 +61.9%	-40.8%	$363.75M	$833.19M	N/A	1,605

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MBOT) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Microbot Medical (MBOT) Competitors

MBOT vs. SI, OBIO, SENS, OFIX, and MOBI

How does Microbot Medical compare to Shoulder Innovations?

Summary

How does Microbot Medical compare to Orchestra BioMed?

Summary

How does Microbot Medical compare to Senseonics Holdings, Inc. Common Stock?

Summary

How does Microbot Medical compare to Orthofix Medical?

Summary

How does Microbot Medical compare to Mobia Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT vs. The Competition

Microbot Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Microbot Medical (MBOT) Competitors

MBOT vs. SI, OBIO, SENS, OFIX, and MOBI

How does Microbot Medical compare to Shoulder Innovations?

Do analysts recommend MBOT or SI?

Does the media favor MBOT or SI?

Is MBOT or SI more profitable?

Do institutionals & insiders have more ownership in MBOT or SI?

Which has more volatility and risk, MBOT or SI?

Which has better earnings and valuation, MBOT or SI?

Summary

How does Microbot Medical compare to Orchestra BioMed?

Which has preferable valuation & earnings, MBOT or OBIO?

Do analysts rate MBOT or OBIO?

Which has more volatility & risk, MBOT or OBIO?

Does the media favor MBOT or OBIO?

Is MBOT or OBIO more profitable?

Do institutionals & insiders hold more shares of MBOT or OBIO?

Summary

How does Microbot Medical compare to Senseonics Holdings, Inc. Common Stock?

Do institutionals and insiders have more ownership in MBOT or SENS?

Does the media refer more to MBOT or SENS?

Is MBOT or SENS more profitable?

Which has better valuation and earnings, MBOT or SENS?

Which has more volatility & risk, MBOT or SENS?

Do analysts recommend MBOT or SENS?

Summary

How does Microbot Medical compare to Orthofix Medical?

Do insiders & institutionals have more ownership in MBOT or OFIX?

Does the media refer more to MBOT or OFIX?

Which has more risk and volatility, MBOT or OFIX?

Do analysts prefer MBOT or OFIX?

Is MBOT or OFIX more profitable?

Which has stronger valuation and earnings, MBOT or OFIX?

Summary

How does Microbot Medical compare to Mobia Medical?

Do insiders and institutionals hold more shares of MBOT or MOBI?

Do analysts recommend MBOT or MOBI?

Which has better earnings & valuation, MBOT or MOBI?

Does the media prefer MBOT or MOBI?

Is MBOT or MOBI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT vs. The Competition

Microbot Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools